BIOLARGO, INC. (51) | Uncategorized (9)

Recent Contracts

Engagement Extension Agreement dated as of March 22, 2022 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 24, 2022)
Agreement dated March 1, 2022, by and between Scion Solutions, LLC, Clyra Medical Technologies, Inc., and BioLargo, Inc (Filed With SEC on March 8, 2022)
Agreement dated March 3, 2022, by and between Clyra Medical Technologies, Inc., and BioLargo, Inc (Filed With SEC on March 8, 2022)
Engagement Extension Agreement dated as of March 18, 2021 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 19, 2021)
Engagement Extension Agreement dated as of February 23, 2020 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on February 27, 2020)
Lock-Up Agreement dated May 28, 2019 (Filed With SEC on June 24, 2019)
Engagement Extension Agreement dated as of January 16, 2019 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on January 18, 2019)
Option to purchase common stock issued to Charles K. Dargan dated December 31, 2017 (Filed With SEC on January 3, 2018)
Engagement Extension Agreement dated as of December 31, 2017 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on January 3, 2018)